Literature DB >> 6845369

Hepatic phase I and phase II biotransformations in quail and trout: comparison to other species commonly used in toxicity testing.

Z Gregus, J B Watkins, T N Thompson, M J Harvey, K Rozman, C D Klaassen.   

Abstract

The ability of quail and trout to perform a number of representative phase I and phase II biotransformations was examined. To facilitate interspecies comparisons, metabolism of the same substrates was examined simultaneously under uniform conditions for rat, mouse, rabbit, guinea pig, cat, and dog. Both nonmammalian species can metabolize four representative substrates of phase I mixed-function oxidases and one substrate of epoxide hydrolase, though activity tended to be lower than that of the mammals. Important differences in the conjugative pathways were also noted. Among these differences were the quail's relative deficiency in glutathione conjugation and the trout's low ability to conjugate sulfate compounds. Trout liver UDP-glucuronosyltransferase activity was remarkably high toward testosterone and bilirubin, while quail liver formed glucuronides of naphthol, p-nitrophenol, and digitoxigenin-monodigitoxoside. Also noteworthy was the high N-acetyltransferase activity of both quail and trout toward isoniazid, beta-naphthylamine, and 2-aminofluorene. Differences in substrate specificity for a given enzymatic pathway may be an indication that multiple forms of drug metabolizing systems also occur in these nonmammalian species. Observation of several hundred- or even thousand-fold differences between species in their enzyme activities for certain substrates under uniform conditions re-emphasizes the need for caution in extrapolation of xenobiotic metabolism from one species to another.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6845369     DOI: 10.1016/0041-008x(83)90327-7

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  11 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Interspecies considerations in the evaluation of human food safety for veterinary drugs.

Authors:  Arthur L Craigmill; Kristy A Cortright
Journal:  AAPS PharmSci       Date:  2002

3.  Retinoids, LRAT and REH activities in eggs of Japanese quail following maternal and in ovo exposures to 3,3',4,4'-tetrachlorobiphenyl.

Authors:  Monique H Boily; Aristocle Ndayibagira; Philip A Spear
Journal:  Ecotoxicology       Date:  2003 Feb-Aug       Impact factor: 2.823

4.  The glutathione S-transferases of fish.

Authors:  I A Nimmo
Journal:  Fish Physiol Biochem       Date:  1987-06       Impact factor: 2.794

5.  Xenobiotic metabolism of plant secondary compounds in oak (Quercus agrifolia) by specialist and generalist woodrat herbivores, genus Neotoma.

Authors:  Shannon L Haley; John G Lamb; Michael R Franklin; Jonathan E Constance; M Denise Dearing
Journal:  J Chem Ecol       Date:  2007-10-11       Impact factor: 2.626

Review 6.  Feline drug metabolism and disposition: pharmacokinetic evidence for species differences and molecular mechanisms.

Authors:  Michael H Court
Journal:  Vet Clin North Am Small Anim Pract       Date:  2013-09       Impact factor: 2.093

Review 7.  12th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals: susceptibility to environmental hazards.

Authors:  J C Barrett; H Vainio; D Peakall; B D Goldstein
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

8.  NMR-based metabolic characterization of chicken tissues and biofluids: a model for avian research.

Authors:  Caroline Ivanne Le Roy; Luke John Mappley; Roberto Marcello La Ragione; Martin John Woodward; Sandrine Paule Claus
Journal:  Metabolomics       Date:  2016-09-15       Impact factor: 4.290

Review 9.  Diseases of quail.

Authors:  H J Barnes
Journal:  Vet Clin North Am Small Anim Pract       Date:  1987-09       Impact factor: 2.093

10.  In vivo and in vitro assessment of mirtazapine pharmacokinetics in cats with liver disease.

Authors:  Rikki L Fitzpatrick; Jessica M Quimby; Kellyi K Benson; Dominique Ramirez; Liberty G Sieberg; Luke A Wittenburg; Daniel L Gustafson
Journal:  J Vet Intern Med       Date:  2018-10-11       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.